Evidence map›Paper›PMID 27215853›Full record

ReviewAgeing research reviews2017

Telomere-associated aging disorders.

Patricia L Opresko, Jerry W Shay

Open access · greenAbstract readReview
In one paragraph

Review in Ageing research reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 4 pooled it
13.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 4 syntheses or guidelines pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Telomere Length and Hearing Loss: A Two-Sample Mendelian Randomization.International journal of environmental research and public health · 2022
    Pooled it
  4. Pooled it
  5. Low-power infrared laser on telomere maintenance in an experimental model of arthritis.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  6. Review
  7. Chronic Kidney Disease and Cellular Senescence.International journal of molecular sciences · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Molecular mechanisms of aging and anti-aging strategies.Cell communication and signaling : CCS · 2024
    Review
  18. Review
  19. Review
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Patricia L OpreskoUniversity of Pittsburgh, Department of Environmental and Occupational Health, and University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213, United States. Electronic address: plo4@pitt.edu.
Jerry W ShayUniversity of Texas Southwestern Medical Center, Department of Cell Biology, 5323 Harry Hines Blvd., Dallas, TX 75390, United States. Electronic address: Jerry.Shay@utsouthwestern.edu.
Southwestern Medical Center · USUPMC Hillman Cancer Center · US

Funding

GENE EXPRESSION IN AGING AND DEVELOPMENTR01AG001228 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI SHAY, JERRY WILLIAM · 1985 to 2018
$7.6M
Cancer Biology Training GrantT32CA124334 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAY, JERRY WILLIAM · 2007 to 2021
$5.3M
Mechanisms of Telomere Resistance to DNA Lesion RemovalR01ES022944 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OPRESKO, PATRICIA L · 2013 to 2017
$1.6M
ROS driven mitochondrial-telomere dysfunction during environmental stressR33ES025606 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OPRESKO, PATRICIA L, VAN HOUTEN, BENNETT · 2017 to 2019
$1.6M
GammaPNA Miniprobes for Telomere FISHR43GM108187 · NIGMS · PNA INNOVATIONS, INC. · PI ARMITAGE, BRUCE A., OPRESKO, PATRICIA L · 2013 to 2014
$541k
Oxidative DNA base damage and repair at telomeres and the relevance to cell senesR21AG045545 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LAN, LI, OPRESKO, PATRICIA L · 2013 to 2014
$422k
ROS driven mitochondrial-telomere dysfunction during environmental stressR21ES025606 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OPRESKO, PATRICIA L, VAN HOUTEN, BENNETT · 2015 to 2016
$414k
NIA NIH HHS R01 AG001228NIA NIH HHS R21 AG045545NIEHS NIH HHS R01 ES022944NIEHS NIH HHS R21 ES025606NIEHS NIH HHS R33 ES025606NIGMS NIH HHS R43 GM108187
6 · The paper itself

Abstract

Telomeres are dynamic nucleoprotein-DNA structures that cap and protect linear chromosome ends. Several monogenic inherited diseases that display features of human premature aging correlate with shortened telomeres, and are referred to collectively as telomeropathies. These disorders have overlapping symptoms and a common underlying mechanism of telomere dysfunction, but also exhibit variable symptoms and age of onset, suggesting they fall along a spectrum of disorders. Primary telomeropathies are caused by defects in the telomere maintenance machinery, whereas secondary telomeropathies have some overlapping symptoms with primary telomeropathies, but are generally caused by mutations in DNA repair proteins that contribute to telomere preservation. Here we review both the primary and secondary telomeropathies, discuss potential mechanisms for tissue specificity and age of onset, and highlight outstanding questions in the field and future directions toward elucidating disease etiology and developing therapeutic strategies.

Indexed as

Aging, PrematureGenetic Diseases, InbornAgingAnimalsDNA RepairHumansMutationSymptom AssessmentTelomeraseTelomereTelomere HomeostasisTelomere ShorteningTelomerasePremature agingRecQ helicasesTelomeraseTelomere

Identifiers

PMID27215853
PMCPMC9926533
OpenAlexW2394983080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.